12-Hour Lung Function Assessment of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Delivered by Co-suspension Delivery Technology in Patients with COPD

被引：0
|
作者：
Ferguson, G. T. [1 ]
Rabe, K. F. [2 ,3 ]
Bourne, E. [4 ]
Ballal, S. [4 ]
DeAngelis, K.
Aurivillius, M. [5 ]
Reisner, C. [5 ]
Dorinsky, P. [4 ]
机构：
[1] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[2] Lungenclin Grosshansdorf GmbH, Zentrum Pneumol & Thoraxchirurg, Grosshansdorf, Germany
[3] Deutsch Zentrum Lungenforsch Dzl, Airway Res Ctr North Arcn, Giessen, Germany
[4] Pearl Astrazeneca, Wedel, Germany
[5] Astrazeneca, Wedel, Germany
来源：
PNEUMOLOGIE | 2020年 / 74卷
关键词：
D O I：
10.1055/s-0039-3403158
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P294
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [21] Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study
    Ferguson, Gary T.
    Papi, Alberto
    Anzueto, Antonio
    Kerwin, Edward M.
    Cappelletti, Christy
    Duncan, Elizabeth A.
    Nyberg, Jack
    Dorinsky, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (03)
  • [22] Single-Inhaler Triple Combination Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) at Two Corticosteroid Dose Levels in COPD: ETHOS Trial
    Rabe, K. F.
    Martinez, F. J.
    Ferguson, G. T.
    Wang, C.
    Singh, D.
    Wedzicha, J. A.
    Trivedi, R.
    St Rose, E.
    Ballal, S.
    McLaren, J.
    Darken, P.
    Aurivillius, M.
    Reisner, C.
    Dorinsky, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALER, FORMULATED USING CO-SUSPENSION DELIVERY TECHNOLOGY, IMPROVES LUNG FUNCTION AND EXACERBATION OUTCOMES IN PATIENTS WITH COPD WITHOUT A RECENT HISTORY OF EXACERBATIONS: SUBGROUP ANALYSIS OF KRONOS STUDY
    Martinez, Fernando
    Ferguson, Gary
    Bourne, Eric
    Ballal, Shaila
    Darken, Patrick
    Deangelis, Kiernan
    Aurivillius, Magnus
    Dorinsky, Paul
    Reisner, Colin
    CHEST, 2019, 156 (04) : 2276A - 2277A
  • [24] Budesonide/glycopyrrolate/ formoterol fumarate metered dose inhaler, formulated using co-suspension delivery technology, improves lung function and exacerbation outcomes in patients with COPD without a recent history of exacerbations: subgroup analysis of KRONOS study
    Martinez, F. J.
    Ferguson, G. T.
    Bourne, E.
    Ballal, S.
    Darken, P.
    DeAngelis, K.
    Aurivillius, M.
    Dorinsky, P.
    Reisner, C.
    PNEUMOLOGIE, 2020, 74 : S44 - S44
  • [25] Efficacy and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (GFF MDI) delivered using co-suspension delivery technology in Japanese patients with moderate-to-very severe COPD
    Gon, Yasuhiro
    Nishi, Koichi
    Sato, Kazuhiro
    Maes, Andrea
    Siddiqui, Shahid
    Hayashi, Nobuya
    Hirata, Hajime
    Reisner, Colin
    Martin, Ubaldo J.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [26] Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) on Symptoms and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the ETHOS Trial
    Martinez, F. J.
    Rabe, K. F.
    Ferguson, G. T.
    Wedzicha, J. A.
    Trivedi, R.
    St Rose, E.
    Ballal, S.
    Darken, P.
    Aurivillius, M.
    Dorinsky, P.
    Reisner, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [27] Ethnic pharmacokinetic comparison of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) between Asian and Western healthy subjects
    Huang, Ying
    Assam, Pryseley Nkouibert
    Feng, Cong
    Su, Rong
    Dorinsky, Paul
    Gillen, Michael
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 64
  • [28] Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD
    Ferguson, Gary T.
    Rodriguez-Roisin, Roberto
    Reisner, Colin
    Maes, Andrea
    Siddiqui, Shahid
    Martin, Ubaldo J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 945 - 953
  • [29] FUNCTIONAL RESPIRATORY IMAGING ASSESSMENT OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AND GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALERS IN PATIENTS WITH COPD
    van den Berge, M.
    De Backer, Jan
    Van Holsbeke, Cedric
    De Backer, Wilfried
    Trivedi, Roopa
    Jenkins, Martin
    Dorinsky, Paul
    Aurivillius, Magnus
    CHEST, 2020, 158 (04) : 1782A - 1783A
  • [30] ETHNIC PHARMACOKINETIC COMPARISON OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALER (BGF MDI) BETWEEN ASIAN AND WESTERN HEALTHY SUBJECTS.
    Huang, Y.
    Assam, P.
    Feng, C.
    Su, R.
    Dorinsky, P.
    Gillen, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S67 - S68
12345